SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
1-Year Est. Return
0.41%
1 Year Est. Return
+0.41%
AUM
$405M
AUM Growth
-$136M
(-25%)
Holding
122
Top Buys
| 1 | +$4.36M | |
| 2 | +$4.16M | |
| 3 | +$3.91M | |
| 4 |
Sarepta Therapeutics
SRPT
|
+$3.77M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
+$3.47M |
Top Sells
| 1 | +$18.6M | |
| 2 | +$6.66M | |
| 3 | +$6.36M | |
| 4 |
Check Point Software Technologies
CHKP
|
+$6.22M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
+$5.29M |
Sector Composition
| 1 | Healthcare | 78.9% |
| 2 | Technology | 13.54% |
| 3 | Consumer Discretionary | 2.19% |
| 4 | Communication Services | 2.14% |
| 5 | Utilities | 1.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teva Pharmaceuticals
TEVA
$22.5B
| $24.2M | 5.56% |
1,572,181
+3,000
|
|
||
|
2
Syndax Pharmaceuticals
SNDX
$1.3B
| $20.4M | 4.71% |
1,663,974
+282,733
|
|
||
3
Sanofi
SNY
$122B
| $16.9M | 3.89% |
304,515
-80,000
|
|
||
4
Nova
NVMI
$9.82B
| $16.7M | 3.85% |
90,697
+22,551
|
|
||
5
AstraZeneca
AZN
$260B
| $12.9M | 2.96% |
175,060
-50,000
|
|
||
6
BridgeBio Pharma
BBIO
$10.5B
| $12.7M | 2.92% |
366,608
-538,671
|
|
||
|
7
Sarepta Therapeutics
SRPT
$2.44B
| $10.1M | 2.32% |
157,931
+59,010
|
|
||
8
Ultragenyx Pharmaceutical
RARE
$3.27B
| $9.68M | 2.23% |
267,385
+38,609
|
|
||
9
Eli Lilly
LLY
$735B
| $9.65M | 2.22% |
11,690
-1,500
|
|
||
10
Celldex Therapeutics
CLDX
$1.76B
| $9.22M | 2.12% |
507,829
+33,726
|
|
||
11
Johnson & Johnson
JNJ
$463B
| $8.76M | 2.02% |
52,831
-17,000
|
|
||
12
Novo Nordisk
NVO
$249B
| $8.2M | 1.89% |
118,080
+20,000
|
|
||
13
Eledon Pharmaceuticals
ELDN
$171M
| $7.82M | 1.8% |
2,307,119
-244,500
|
|
||
14
Mineralys Therapeutics
MLYS
$3.33B
| $7.39M | 1.7% |
465,526
+274,854
|
|
||
15
Amazon
AMZN
$2.29T
| $6.96M | 1.6% |
36,607
-26,000
|
|
||
16
AbbVie
ABBV
$401B
| $6.34M | 1.46% |
30,256
-4,000
|
|
||
17
Pharvaris
PHVS
$1.41B
| $6.03M | 1.39% |
383,856
-4,327
|
|
||
18
Ormat Technologies
ORA
$6.68B
| $5.94M | 1.37% |
84,000
+5,000
|
|
||
19
Cytokinetics
CYTK
$7.05B
| $5.83M | 1.34% |
144,961
-8,060
|
|
||
20
Meta Platforms (Facebook)
META
$1.79T
| $5.74M | 1.32% |
9,962
-11,039
|
|
||
21
Novartis
NVS
$253B
| $5.57M | 1.28% |
50,000
|
|
||
22
Merck
MRK
$210B
| $5.35M | 1.23% |
59,600
|
|
||
23
Praxis Precision Medicines
PRAX
$3.42B
| $5.33M | 1.23% |
140,660
+49,077
|
|
||
24
Nice
NICE
$7.92B
| $5.13M | 1.18% |
33,303
-9,197
|
|
||
25
GSK
GSK
$88B
| $5.04M | 1.16% |
130,000
|
|